Lilly, LifeMD and Teladoc
Wegovy Gets Cheaper! Novo Nordisk Takes on Eli Lilly
8h
Health on MSNZepbound Is Now Available in Additional Doses at Lower CostsEli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.
A U.S. federal judge has denied an injunction that would have allowed compounding pharmacies to keep making copies of Eli ...
6d
Verywell Health on MSNEli Lilly Lowers Cost of Zepbound Vials To Attract People Without Insurance CoverageEli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people ...
Teladoc Health teams up with Eli Lilly's LillyDirect to improve Zepbound access, offering direct home delivery and comprehensive obesity care support.
Hims & Hers (NYSE:HIMS) fell ~8% in the premarket Thursday after a federal judge denied a motion filed by a compounding trade ...
Bernstein analysts told investors in a note Tuesday that Eli Lilly (NYSE:LLY) is gaining ground in the GLP-1 market, edging closer to market share parity with Novo Nordisk (NYSE:NVO).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results